Global Immune Checkpoint Inhibitors Market to Cross USD 100 Billion by 2032 | DelveInsight

The growing demand for immune checkpoint inhibitors is mainly driven by the rising incidence of lung cancer, the increasing prevalence of melanoma, and the expanding number of research studies related to immune checkpoint inhibitors, among other factors, throughout the forecast period from 2025 to 2032. New York, USA, Feb. 18, 2025 (GLOBE NEWSWIRE) — Global […]